Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 2.870
+0.010 (0.35%)
Jan 21, 2026, 3:15 PM HKT
Luye Pharma Group Revenue
Luye Pharma Group had revenue of 3.18B CNY in the half year ending June 30, 2025, with 9.54% growth. This brings the company's revenue in the last twelve months to 6.17B, down -2.31% year-over-year. In the year 2024, Luye Pharma Group had annual revenue of 6.06B, down -1.33%.
Revenue (ttm)
6.17B CNY
Revenue Growth
-2.31%
P/S Ratio
1.69
Revenue / Employee
1.20M CNY
Employees
5,150
Market Cap
11.42B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | 5.54B | -818.21M | -12.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsLuye Pharma Group News
- 27 days ago - Luye Pharma Grants Nhwa Rights To Commercialize Three LAI Antipsychotics In Chinese Mainland - Nasdaq
- 1 year ago - RRJ Buys $150 Million Luye Bonds, First China Deal Since 2019 - BNN Bloomberg